Johnson & Johnson is reinforcing its case as a defensive healthcare holding after lifting full-year guidance despite a share decline following its second-quarter results. The update points to ...
Johnson & Johnson (JNJ) stock is trading at $246.35 after a daily decline of 3.26%. The price currently sits below its key moving averages on the short- and medium-term, ...
Investor focus is shifting to corporate guidance as the earnings season accelerates and uneven stock reactions test confidence in stretched valuations. At the same time, rising oil prices linked ...
Johnson & Johnson (JNJ) closed the week at $256.61, marking a modest decline of $0.45 (0.03%) from the previous week's close and holding at the very bottom of its ...
The White House is preparing a new voluntary pledge that seeks to keep the fast-rising electricity needs of artificial intelligence from pushing up power bills for households and businesses. The ...
U.S. equities are edging higher at the end of the week as investors position for a heavy run of second-quarter results across banking, healthcare, semiconductors and streaming. The earnings ...
Semiconductor stocks are losing ground as investors rotate within the chip sector and assess new opportunities tied to AI demand. Intel is drawing particular attention after a sharp weekly drop, ...
Johnson & Johnson (JNJ) rallied 3.03% as resilient financial results and robust cash flow fueled renewed buying interest. The move is supported by the stock trading well above its 20-day, 50-day, ...
Johnson & Johnson (JNJ) stock is trading at $268.2, up 3.42% today. The price sits above its key moving averages, signaling strong near-term momentum and broad technical ...
Johnson & Johnson (JNJ) shares are currently trading at $257.21, down $5.19 or 1.92% over the past week. The price remains well above its weekly MA-20 ($237.26), MA-50 ...
The U.S. Food and Drug Administration is selecting an initial group of drugmakers for a pilot program aimed at shortening the review process for new domestic pharmaceutical manufacturing sites. ...
Republican-backed Working Families Tax Cuts are being presented as strengthening the investment climate for U.S. manufacturers and workers. Johnson & Johnson says the policy framework supports its ...
Johnson & Johnson (JNJ) is currently trading at $254.95, having increased by $0.89 or 0.36% over the past week. The stock sits well above its weekly MA-20 ($236.31), ...
A rotation away from AI-linked trades is pushing healthcare shares sharply higher at the end of the week, even as the broader U.S. stock market remains volatile. Cardinal Health, Johnson & Johnson ...
Johnson & Johnson (JNJ) stock is trading at $253.35 after a strong surge of 3.51% on the day, marking a clear advance. The price remains well above its key moving ...
Johnson & Johnson (JNJ) stock is trading at $238.41, advancing 3.11% for the session. The price currently sits above its key short- and medium-term moving averages, ...
Johnson & Johnson (JNJ) shares are currently trading at $228.35, reflecting a weekly decline of $11.77, or 4.9%. The price is below the weekly MA-20 at $235.62, just ...
Johnson & Johnson (JNJ) is trading at $238.90, finishing the week up $6.15 (2.57%). The asset remains above its weekly MA-20 ($235.47), MA-50 ($207.27), and MA-200 ...
Pharmaceutical shares are gaining leadership within healthcare as sector momentum improves against the broader market. That shift is supporting expectations that other large-cap drugmakers could ...
As the Ebola outbreak response continues in the Democratic Republic of the Congo and Uganda, the U.S. Department of State is adding nearly $38 million to its direct funding effort. The increase ...
Defensive sectors are leading the market in Friday midday trading as investors pull back from technology and crypto-linked shares. The sharpest moves include fresh weakness in semiconductor ...